Vascular endothelial growth factor-A165b restores normal glomerular water permeability in a diphtheria-Toxin mouse model of glomerular injury

Megan Stevens, Christopher R. Neal, Andrew H.J. Salmon, David O. Bates, Steven J. Harper, Sebastian Oltean

Research output: Contribution to journalArticle (Academic Journal)peer-review

2 Citations (Scopus)
168 Downloads (Pure)


Background/Aims: Genetic cell ablation using the human diphtheria toxin receptor (hDTR) is a new strategy used for analysing cellular function. Diphtheria toxin (DT) is a cytotoxic protein that leaves mouse cells relatively unaffected, but upon binding to hDTR it ultimately leads to cell death. We used a podocyte-specific hDTR expressing (Pod-DTR) mouse to assess the anti-permeability and cyto-protective effects of the splice isoform vascular endothelial growth factor (VEGF-A165b). Methods: The Pod-DTR mouse was crossed with a mouse that over-expressed VEGF-A165b specifically in the podocytes (Neph-VEGF-A165b). Wild type (WT), Pod-DTR, Neph-VEGF-A165b and Pod-DTR X Neph-VEGF-A165b mice were treated with several doses of DT (1, 5, 100, and 1,000 ng/g bodyweight). Urine was collected and the glomerular water permeability (LpA/Vi) was measured ex vivo after 14 days. Structural analysis and podocyte marker expression were also assessed. Results: Pod-DTR mice developed an increased glomerular LpA/Vi 14 days after administration of DT (all doses), which was prevented when the mice over-expressed VEGF-A165b. No major structural abnormalities, podocyte ablation or albuminuria was observed in Pod-DTR mice, indicating this to be a mild model of podocyte disease. However, a change in expression and localisation of nephrin within the podocytes was observed, indicating disruption of the slit diaphragm in the Pod-DTR mice. This was prevented in the Pod-DTR X Neph-VEGF-A165b mice. Conclusion: Although only a mild model of podocyte injury, over-expression of the anti-permeability VEGF-A165b isoform in the podocytes of Pod-DTR mice had a protective effect. Therefore, this study further highlights the therapeutic potential of VEGF-A165b in glomerular disease.

Original languageEnglish
Pages (from-to)51-62
Number of pages12
JournalNephron Physiology
Issue number1
Early online date26 Jan 2018
Publication statusPublished - 1 Apr 2018


  • Diphtheria-Toxin
  • Glomerulus
  • Permeability
  • Podocyte
  • Vascular endothelial growth factor-Ab


Dive into the research topics of 'Vascular endothelial growth factor-A<sub>165</sub>b restores normal glomerular water permeability in a diphtheria-Toxin mouse model of glomerular injury'. Together they form a unique fingerprint.

Cite this